Share
Join us for this live program designed to address educational needs specific to advanced practice providers who care for patients with cancer. These webinars will navigate insights and updates across multiple cancer types and deliver innovative, real-time education to nurse practitioners and physician associates worldwide. Our mission is to bridge knowledge gaps, untangle controversies, and spotlight pivotal data in a digestible and engaging format.
Physicians ABIM MOC: maximum of 2.00 Medical Knowledge MOC points
Physicians: maximum of 2.00 AMA PRA Category 1 Credits™
Physician Assistants/Physician Associates: 3.00 AAPA Category 1 CME credits
Pharmacists: 2.00 contact hours (0.2 CEUs)
Nurse Practitioners/Nurses: 3.00 Nursing contact hours
This activity is intended for nurse practitioners, nurses, physician associates, and other healthcare professionals who care for patients with cancer.
Saturday, September 19, 2026
8:30 AM - 1:40 PM Eastern Time (ET)
Virtual
8:30 AM - 8:35 AM - Welcome and Opening Remarks
8:35 – 9:35 AM – Multidisciplinary Strategies for Integrating Immunotherapy Into Patient-Centered Management of Resectable Early-Stage NSCLC
9:35 AM - 10:35 AM – Nonaccredited Educational Session, managed by Decera Clinical Insights
10:35 AM - 11:35 AM – Optimizing Prevention and Management of Tumor Lysis Syndrome in Patients With Hematologic Malignancies: A Grand Rounds Workshop Series
Faculty: James A. Davis, PharmD, BCOP
11:35 AM - 12:35 PM – Thrombotic Risk and Symptom Burden in Patients With Polycythemia Vera | Identifying When to Intervene With JAKAFI®/JAKAFI XRTM (ruxolitinib)
Presented by Christopher Nelson, MSN, ACNP-BC, MBA
This non-CME educational program is sponsored by Incyte and managed by Decera Clinical Insights.
12:35 PM - 1:35 PM – Improving Outcomes with Oral SERDs in MBC: Case Challenges and Skill-Building Strategies for the Advanced Practice Provider
1:35 - 1:40 PM – Summary and Closing Remarks
Multidisciplinary Strategies for Integrating Immunotherapy into Patient-Centered Management of Resectable Early-Stage NSCLC
Goal Statement
This activity aims to elevate learners' knowledge, confidence, and competence at providing patient-centric, guideline-concordant multidisciplinary care to each individual with resectable early-stage NSCLC eligible for neo/adjuvant immunotherapy-based treatment.
Target Audience
This activity is intended for medical oncologists, surgical oncologists, surgeons, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals involved in the multidisciplinary care of patients with resectable early-stage NSCLC in community and academic practices.
Learning Objectives
Upon completion of this activity, participants should be able to:
Optimizing Prevention and Management of Tumor Lysis Syndrome in Patients With Hematologic Malignancies: A Grand Rounds Workshop Series
Goal Statement
This activity aims to improve learners’ knowledge, confidence, and competence at preventing, identifying, and managing tumor lysis syndrome in patients with hematologic malignancies.
Target Audience
This activity is intended for hematologists, oncologists, emergency room specialists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals who care for patients at risk of developing tumor lysis syndrome.
Learning Objectives
Upon completion of this event, participants should be able to:
Improving Outcomes with Oral SERDs in MBC: Case Challenges and Skill-Building Strategies for the Advanced Practice Provider
Goal Statement
This activity aims to equip learners with the education, skills, and resources needed to employ shared decision-making and communication strategies to improve adherence, manage treatment-related adverse events, and counsel patients initiating or switching to oral SERD therapy.
Target Audience
This program is intended for nurse practitioners, physician associates, clinical nurse specialists, and advanced degree nurses who care for patients with HR-positive/HER2-negative metastatic breast cancer.
Learning Objectives
Upon completion of this event, participants should be able to:
Multidisciplinary Strategies for Integrating Immunotherapy into Patient-Centered Management of Resectable Early-Stage NSCLC
Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC dba Decera Clinical Education and Smart Patients. Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-9999-26-412-L0
Type of Activity: Application
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.
American Board of Internal Medicine Maintenance of Certification 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.
For ABIM MOC points, your information will be shared with the ABIM through Decera Clinical Education’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
By sharing your Diplomate Board ID # and DOB, you are giving Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).
CME for MIPS

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).
In order to fulfill requirements for MIPS improvement activity, learners will need to fill out 2 brief follow-up surveys at 30 and 90 days post activity.
IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.
Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Optimizing Prevention and Management of Tumor Lysis Syndrome in Patients With Hematologic Malignancies: A Grand Rounds Workshop Series
Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-26-417-L01-P
Type of Activity: Application
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.
American Board of Internal Medicine Maintenance of Certification 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.
For ABIM MOC points, your information will be shared with the ABIM through Decera Clinical Education’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
By sharing your Diplomate Board ID # and DOB, you are giving Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).
IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.
Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Improving Outcomes with Oral SERDs in MBC: Case Challenges and Skill-Building Strategies for the Advanced Practice Provider
Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.
IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Multidisciplinary Strategies for Integrating Immunotherapy into Patient-Centered Management of Resectable Early-Stage NSCLC
Provided by Clinical Care Options, LLC dba Decera Clinical Education, in partnership with Smart Patients.
Supported by an educational grant from Merck Sharp & Dohme LLC.
Optimizing Prevention and Management of Tumor Lysis Syndrome in Patients With Hematologic Malignancies: A Grand Rounds Workshop Series
Provided by Clinical Care Options, LLC dba Decera Clinical Education.
This activity is supported by an educational grant from Sanofi Genzyme.
Improving Outcomes with Oral SERDs in MBC: Case Challenges and Skill-Building Strategies for the Advanced Practice Provider
Provided by Clinical Care Options, LLC dba Decera Clinical Education.
This activity is supported by educational grants from AstraZeneca and Stemline Therapeutics, Inc.
Provided by Clinical Care Options, LLC dba Decera Clinical Education
This activity is supported by educational grants from Merck Sharp & Dohme LLC., Sanofi Genzyme, AstraZeneca and Stemline Therapeutics, Inc.
AstraZeneca
Sanofi Genzyme
Stemline Therapeutics, Inc.
Merck Sharp & Dohme LLC
For customer support please click here.
|
Mailing Address: |
|
Decera Clinical Education |
There are no fees required to participate in this activity.
Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.